Related Experiment Videos
BRaf signaling principles unveiled by large-scale human mutation analysis with a rapid lentivirus-based gene
Chae-Seok Lim1,2, Xi Kang1, Vincent Mirabella3,4
1Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Genes & Development
|April 14, 2017
Summary
Researchers identified the BRAF gene as crucial for cell signaling in neurodevelopmental disorders like cardio-facio-cutaneous syndrome (CFC). This discovery aids precision medicine by detailing gene-mutation-cell relationships.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Genetic mutations are increasingly linked to diseases, necessitating a deeper understanding of gene-mutation-cell behavior for precision medicine.
- Over 350 BRAF gene mutations are associated with various cancers, and approximately 40 are linked to cardio-facio-cutaneous syndrome (CFC).
Purpose of the Study:
- To develop a rapid, cost-effective method for analyzing the functional impact of BRAF gene mutations, including those causing CFC.
- To investigate the role of BRAF in the signaling pathways underlying neuronal function and disease.
Main Methods:
- A lentivirus-based gene replacement technique was employed to study BRAF and its disease-linked mutants.
- Simultaneous multiple patch-clamp recordings were performed on over 6000 pairs of rat, mouse, and human neurons.
- Behavioral learning tests were conducted on over 1400 rats.
Main Results:
- BRAF was identified as a critical signaling effector in the NMDA-R-CaMKII-SynGap-Ras-BRAF-MEK-ERK pathway.
- The study generated extensive data on BRAF signaling, revealing three key characteristics.
- The developed method enables large-scale functional analysis of disease-linked mutations.
Conclusions:
- This research establishes an efficient platform for the functional assessment of numerous human disease-associated mutations.
- The findings are essential for advancing precision medicine by clarifying gene-mutation-cell-behavior links.